Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,229 | 34,221 | 8,433 | 13,051 | 9,536 |
| Receivables | 40,100 | 36,793 | 35,233 | 36,291 | 33,833 |
| Income taxes - deferred | 1,933 | 1,854 | 1,777 | 963 | 963 |
| Other current assets | 8,166 | 7,571 | 4,834 | 8,064 | 7,138 |
| TOTAL | $68,428 | $80,439 | $53,428 | $58,369 | $51,470 |
| Non-Current Assets | |||||
| PPE Net | 313,577 | 270,794 | 243,074 | 224,238 | 181,386 |
| Investments And Advances | 13,162 | 6,958 | 6,356 | 3,022 | 4,030 |
| Intangibles | 57,955 | 55,929 | 56,241 | 56,533 | 56,831 |
| TOTAL | $384,694 | $333,681 | $305,671 | $283,793 | $242,247 |
| Total Assets | $453,122 | $414,120 | $359,099 | $342,162 | $293,717 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 56,766 | 80,412 | 49,581 | 60,881 | 51,819 |
| Accrued Expenses | 5,526 | 3,823 | 1,411 | 5,921 | 4,346 |
| TOTAL | $70,825 | $88,426 | $54,767 | $67,653 | $57,154 |
| Non-Current Liabilities | |||||
| Long Term Debt | 193,100 | 165,100 | 147,600 | 127,500 | 93,090 |
| Deferred Revenues | 3,854 | 4,191 | 3,744 | 731 | 782 |
| TOTAL | $238,761 | $188,820 | $173,184 | $149,678 | $117,503 |
| Total Liabilities | $309,586 | $277,246 | $227,951 | $217,331 | $174,657 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,142 | 17,145 | 17,145 | 17,145 | 17,146 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | 51,610 | 45,346 | 40,057 | 33,947 | 28,546 |
| Other shareholders' equity | 436 | 242 | 101 | 191 | 102 |
| TOTAL | $143,536 | $136,874 | $131,148 | $124,831 | $119,060 |
| Total Liabilities And Equity | $453,122 | $414,120 | $359,099 | $342,162 | $293,717 |